Tom Scales is Senior Vice President of Market Access & Public Affairs and Patient Support Solutions at Novo Nordisk, a role he assumed in March 2026. In this role, Tom leads US market access and public affairs strategy, advancing patient access to innovative therapies and engaging key stakeholders across the healthcare ecosystem to help improve health outcomes for people living with serious chronic diseases.

A seasoned healthcare executive with more than two decades of leadership experience across biopharmaceuticals and digital health, Tom brings deep expertise in market access, payer strategy, and commercial execution. He is known for developing innovative access models, strengthening payer and stakeholder partnerships, and delivering sustainable growth in highly complex healthcare environments.

Prior to joining Novo Nordisk, Tom served as Senior Vice President of Sales and Payer Access at Omada Health, where he led health plan, PBM, health system, and employer partnerships and advanced access strategies focused on cardiometabolic and obesity care. Earlier in his career, he held commercial leadership roles at leading healthcare organizations including Eli Lilly and Company, GSK, and Intercept Pharmaceuticals, with a consistent focus on expanding patient access and driving long‑term value.

Tom is recognized for his people‑first leadership style, leading with integrity, clarity, and collaboration. He is committed to building high‑performing, inclusive teams, empowering leaders at every level, and keeping patients at the center of decision‑making. His approach balances strategic rigor with empathy and transparency, fostering cultures that enable both strong performance and meaningful impact.

Tom holds dual Bachelor of Arts degrees in English and Psychology from Vanderbilt University and an MBA from the McCombs School of Business at The University of Texas at Austin. Earlier in his career, he served as a Peace Corps Volunteer in Paraguay.